Detalhe da pesquisa
1.
Impact of TP53 on outcome of patients with myelofibrosis undergoing hematopoietic stem cell transplantation.
Blood
; 141(23): 2901-2911, 2023 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36940410
2.
Peripheral and Portal Venous KRAS ctDNA Detection as Independent Prognostic Markers of Early Tumor Recurrence in Pancreatic Ductal Adenocarcinoma.
Clin Chem
; 69(3): 295-307, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36644936
3.
Molecular monitoring of T-cell kinetics and migration in severe neurotoxicity after real-world CD19-specific chimeric antigen receptor T cell therapy.
Haematologica
; 108(2): 444-456, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35950534
4.
Individualized busulfan dosing improves outcomes compared to fixed-dose administration in pre-transplant minimal residual disease-positive acute myeloid leukemia patients with intermediate-risk undergoing allogeneic stem cell transplantation in CR.
Eur J Haematol
; 110(2): 188-197, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36335432
5.
Comprehensive clinical-molecular transplant scoring system for myelofibrosis undergoing stem cell transplantation.
Blood
; 133(20): 2233-2242, 2019 05 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30760453
6.
Role of pre-transplant MRD level detected by flow cytometry in recipients of allogeneic stem cell transplantation with AML.
Eur J Haematol
; 106(5): 606-615, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33249666
7.
Clonal Evolution after Allogeneic Hematopoietic Stem Cell Transplantation: The Case of Myelofibrosis.
Biol Blood Marrow Transplant
; 26(7): e167-e170, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32147533
8.
Reduced intensity allogeneic stem cell transplantation for younger patients with myelofibrosis.
Br J Haematol
; 186(3): 484-489, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31090920
9.
Allogeneic stem cell transplantation in patients with myelofibrosis harboring the MPL mutation.
Eur J Haematol
; 103(6): 552-557, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31446640
10.
Peritransplantation Ruxolitinib Prevents Acute Graft-versus-Host Disease in Patients with Myelofibrosis Undergoing Allogenic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 24(10): 2152-2156, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29800615
11.
Impact of ruxolitinib pretreatment on outcomes after allogeneic stem cell transplantation in patients with myelofibrosis.
Eur J Haematol
; 101(3): 305-317, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29791053
12.
Impact of Molecular Genetics on Outcome in Myelofibrosis Patients after Allogeneic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 23(7): 1095-1101, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28389256
13.
Correlation of somatic mutations with outcome after FLAMSA-busulfan sequential conditioning and allogeneic stem cell transplantation in patients with myelodysplastic syndromes.
Eur J Haematol
; 97(3): 288-96, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26680262
14.
Postallogeneic monitoring with molecular markers detected by pretransplant next-generation or Sanger sequencing predicts clinical relapse in patients with myelodysplastic/myeloproliferative neoplasms.
Eur J Haematol
; 92(3): 189-94, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24164563
15.
5-azacytidine promotes an inhibitory T-cell phenotype and impairs immune mediated antileukemic activity.
Mediators Inflamm
; 2014: 418292, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24757283
16.
CD19-targeted chimeric antigen receptor T cell therapy in two patients with multiple sclerosis.
Med
; 5(6): 550-558.e2, 2024 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38554710
17.
Graft-versus-host disease and impact on relapse in myelofibrosis undergoing hematopoietic stem cell transplantation.
Bone Marrow Transplant
; 59(4): 550-557, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38321269
18.
Impact of high-risk cytogenetics and achievement of molecular remission on long-term freedom from disease after autologous-allogeneic tandem transplantation in patients with multiple myeloma.
Biol Blood Marrow Transplant
; 19(3): 398-404, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23078786
19.
Use of ropeginterferon in inducing graft versus myelofibrosis effect in post-transplant myelofibrosis relapse.
Clin Case Rep
; 11(9): e7942, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37744628
20.
Donor Lymphocyte Infusion and Molecular Monitoring for Relapsed Myelofibrosis After Hematopoietic Cell Transplantation.
Hemasphere
; 7(7): e921, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37404772